Repaglinide induced Acute Hepatotoxicity | Zendy

Suresh Jaiswal | Zendy; Rohtesh S. Mehta | Zendy; Manisha Reddy Musuku | Zendy; Linda Tran | Zendy; Jr W McNamee | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Repaglinide induced Acute Hepatotoxicity

Author(s) -

Suresh Jaiswal,

Rohtesh S. Mehta,

Manisha Reddy Musuku,

Linda Tran,

Jr W McNamee

Publication year - 2009

Publication title -

journal of nepal medical association

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.176

H-Index - 19

eISSN - 1815-672X

pISSN - 0028-2715

DOI - 10.31729/jnma.236

Subject(s) - repaglinide , medicine , vomiting , hypoglycemia , nausea , diarrhea , ingestion , adverse effect , gastroenterology , metformin , insulin

Repaglinide is considered a safe drug; adverse events are mild to moderate which includes hypoglycemia, headache, nausea, vomiting, diarrhea and dyspepsia as similar to sulphonylureas. This case report describes a rare side effect of repaglinide. In rare cases, elevated liver enzymes have been noted. We report a case of acute hepatotoxicity in a 78 year old woman who developed acute hepatotoxicity while taking repaglinide.Key Words: hepatotoxicity, hypoglycemia, repaglinide,

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research